+1 Recommend
0 collections
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Promising of Multidrug-resistant Tuberculosis Screening among New Tuberculosis Patients in China

      1 , 2
      Chinese Medical Journal
      Medknow Publications & Media Pvt Ltd

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Peng et al.[1] reported that the MDR-TB burden among the new tuberculosis (TB) patients accounted for more than 1/4th of all multidrug-resistant TB (MDR-TB) cases in the past 5 years in Zhejiang province, although the identified rate of MDR-TB among 9830 new TB cases was only 2.0%. Drug-resistant TB, especially MDR-TB, is a major threat to the control of TB worldwide. However, due to high cost and limited budget, screening on MDR-TB has not been implemented among all TB cases by now. A Chinese survey indicated that the prevalence of MDR-TB was 5.7% in the new TB cases and 25.6% in the previously treated cases in 2007. In the period of 2011–2015, MDR-TB screening has been provided for the patients who are at high risk of drug-resistant TB in the National TB Control Program (NTP) implementation. It was estimated that there were 57,000 MDR/rifampicin-resistant (MDR/RR)-TB cases among the notified pulmonary TB cases in 2015 in China, but only 9662 MDR/RR cases were identified, this figure was much lower in comparison with the estimated cases. Clearly, most MDR-TB cases have been lost due to limited coverage of drug-resistant screening. Fortunately, this situation will be changed sooner with the development of technologies and economy in China. The technologies of MDR-TB tests developed rapidly in the recent years, such as GeneXpert® recommended by the WHO, substantially reduced the time needed for diagnosis. The “13th Five-Year Plan” of China NTP promised that all suspected pulmonary TB patients will be provided for sputum smear and culture examination and drug-resistance will be of course screened for etiologically positive pulmonary TB patients, including both new TB and those at high risk of MDR-TB. The county-level hospitals will take the important roles to diagnose TB cases and screening MDR-TB timely. This is an undoubtedly ambitious plan for screening MDR-TB among one million TB cases, of which more than 85% are new TB cases. However, the preliminary study of Peng et al. presented a promising and encouraging perspective for this plan, and we truly expect and indeed believe that the “13th Five-Year Plan” will bring a different contribution to control TB in China. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013

          Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious TB subpopulations excluding the new TB patients. This study aimed to examine MDR-TB burden among the new TB patients. Methods: We conducted a study in Zhejiang Province during 2009–2013 to screen for MDR-TB patients among the low MDR-TB risk patients and five subpopulations of high MDR-TB risk patients. The number, prevalence, and trend of MDR-TB were compared while the logistic regression model was used to examine risk factors related to MDR-TB. Results: A total of 200 and 791 MDR-TB cases were, respectively, identified from the 9830 new TB cases and 2372 high-risk suspects who took MDR-TB screening from 2009 to 2013. The MDR-TB rates went down in both of the new TB patients and five MDR-TB high-risk groups over the study time, but the percentage of MDR-TB patients identified from the new TB patients in all diagnosed MDR-TB cases kept stable from 28.3% in 2011 to 27.0% in 2012 to 26.0% in 2013. Conclusions: The study indicated that MDR-TB burden among new TB patients was high, thus screening for MDR-TB among the new TB patients should be recommended in China as well as in the similar situation worldwide.

            Author and article information

            Chin Med J (Engl)
            Chin. Med. J
            Chinese Medical Journal
            Medknow Publications & Media Pvt Ltd (India )
            05 September 2017
            : 130
            : 17
            : 2142
            [1 ]National Center for Tuberculosis Prevention and Control, Chinese Center For Disease Control And Prevention, Beijing 102206, China
            [2 ]National Institute of Drug Dependence, Peking University, Beijing 100191, China
            Author notes
            Address for correspondence: Dr. Hui Zhang, National Center for Tuberculosis Prevention and Control, Chinese Center For Disease Control and Prevention, No.155 Changbai Road, Changping District, Beijing 102206, China E-Mail: zhanghui@ 123456chinatb.org
            Copyright: © 2017 Chinese Medical Journal

            This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

            : 13 July 2017


            Comment on this article